中国，北京——2025年9月4日——在伊斯兰共和国巴基斯坦总理阁下的见证下，海杰亚医疗与巴基斯坦SHAHCO MEDICAL在第二届中巴投资对接大会上签署了战略性谅解备忘录（MoU）。

Beijing, China – September 4, 2025 – In a significant ceremony witnessed by His Excellency the Prime Minister of the Islamic Republic of Pakistan, Hygea Medical Technology Co., Ltd. of China and SHAHCO MEDICAL Pvt Ltd of Pakistan signed a strategic Memorandum of Understanding (MoU) today at the 2nd Pakistan-China B2B Investment Conference.

此次签约仪式在巴基斯坦总理及多位高级部长的见证下举行，标志着中巴在医疗健康领域合作迈出重要一步。该谅解备忘录致力于通过引入创新性的复合式冷热消融（co-ablation）技术，提升巴基斯坦癌症治疗水平。

The signing, which took place during the high-profile conference attended by the Pakistani Premier and senior ministers, marks a major step in strengthening Sino-Pakistani cooperation in the healthcare sector. The MoU is squarely focused on advancing cancer treatment capabilities in Pakistan through the introduction of innovative co-ablation technology.

巴基斯坦总理的出席与见证，凸显了这一医疗项目所获得的高层政治承诺，以及其与中巴经贸和技术合作总体框架的契合。

The presence and witness of the Prime Minister of Pakistan underscore the high-level political commitment to this healthcare initiative and its alignment with the broader framework of Pakistan-China economic and technological collaboration.

该协议体现了海杰亚医疗与SHAHCO MEDICAL 公司的共同愿景，即通过创新、培训与合作，为减轻巴基斯坦的癌症负担作出重要贡献。

This agreement reflects a shared vision between Hygea and SHAHCO to significantly contribute to reducing the cancer burden in Pakistan through innovation, training, and partnership.